Effectiveness of milnacipran for SSRI-intolerant patients with premenstrual dysphoric disorder [8]

Journal of Clinical Psychopharmacology

Volumn 25, Issue 4, 2005, Pages 398-399

  Yamada, Kazuo ^a   Kanba, Shigenobu ^b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; FLUVOXAMINE; MILNACIPRAN; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; CASE REPORT; DEPRESSION; DRUG EFFICACY; DYSPEPSIA; FEMALE; HUMAN; LETTER; MENSTRUAL CYCLE; NAUSEA; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SOMNOLENCE; TREATMENT OUTCOME; VOMITING;

ADRENERGIC UPTAKE INHIBITORS; ADULT; CYCLOPROPANES; FEMALE; HUMANS; NOREPINEPHRINE; PREMENSTRUAL SYNDROME;

EID: 23044490699     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000169618.99700.78     Document Type: Letter

References (3)

1. Yonkers KA. Antidepressants in the treatment of premenstrual dysphoric disorder. J Clin Psychiatry. 1997;58(suppl 14):4-10.
2. Spencer CM, Wilde MI. Milnacipran. A review of its use in depression. Drugs. 1998;56:405-427.
3. Freeman EW, Rickels K, Yonkers KA, et al. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol. 2001;98: 737-744.